← All trials
NCT06456723
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 14, 2014
- Primary completion
- Oct 17, 2018
- Completion date
- Oct 17, 2018
- First posted
- Jun 13, 2024
- Last posted
- Jun 13, 2024
- Enrollment
- 59
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Imperial College LondonLead sponsor
- Imperial College LondonOfficial
- The Christie NHS Foundation TrustCollaborator
- University of LondonCollaborator
- Royal Marsden Hospital NHS TrustCollaborator
- University of ManchesterCollaborator
- Newcastle UniversityCollaborator
- InvicroCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.